Skip to main content
. 2023 Jul 7;14:1190663. doi: 10.3389/fphar.2023.1190663

TABLE 8.

Serum lipid parameter of hyperlipidemic volunteers at baseline, day 30, and day 60 during phase 2 (mean ± SD).

Control 250 mg OPP
Total cholesterol (mmol/L)
 Day 1 5.78 ± 0.52 5.76 ± 0.54
 Day 30 5.56 ± 0.66a 5.54 ± 0.68a
 Day 60 5.51 ± 0.49a 5.49 ± 0.67a
HDL (mmol/L)
 Day 1 1.30 ± 0.25 1.37 ± 0.34
 Day 30 1.26 ± 0.23 1.40 ± 0.34
 Day 60 1.34 ± 0.24c 1.42 ± 0.34
LDL (mmol/L)
 Day 1 3.88 ± 0.51 3.82 ± 0.59
 Day 30 3.67 ± 0.62a 3.59 ± 0.63a
 Day 60 3.51 ± 0.60b 3.53 ± 0.69a
Triglycerides (mmol/L)
 Day 1 1.30 ± 0.82 1.25 ± 0.54
 Day 30 1.38 ± 0.62 1.23 ± 0.55
 Day 60 1.46 ± 0.90 1.16 ± 0.46

Abbreviation: TC, total cholesterol; TG, triglycerides; LDL, low-density lipoprotein; HDL, high-density lipoprotein.

aSignificantly different compared to day 1 within the group (p < 0.05).

bSignificantly different compared to day 1 within the group (p < 0.001).

cSignificantly different compared to day 30 within the group (p < 0.05).